Elderly Women and the Risk of Breast Cancer When Initiating Certain Insulins
Apr 18, 2020
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Deonna Andrews, PharmD Candidate 2020 of Florida Agricultural & Mechanical University College of Pharmacy and Pharmaceutical Sciences
Insulin has changed the game in managing people with diabetes but has the potential to cause unwanted severe adverse effects in women 65 years of age and older.
Designed to overcome the limitations of neutral protamine Hagedorn insulin, long-acting insulin analogs such as glargine and detemir have become novel treatments in the management of chronic disease, diabetes. These structurally altered human insulins are thought to influence mitogenicity, which raised concerns in scientists about the potential glargine had to be carcinogenic....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.